Background
Methods
Design
Participants and recruitment
Randomization and blinding
SCP care versus usual care
Survivorship care plan
Measures
Statistical analysis
Results
Endometrial cancer | Ovarian cancer | |||||
---|---|---|---|---|---|---|
SCP care (N = 119) | Usual care (N = 102) | P value | SCP care (n = 61) | Usual care (n = 113) | P value* | |
Age at survey | ||||||
Mean (SD) | 67.4 (9.1) | 67.8 (8.9) | 0.71 | 63.6 (11.2) | 64.3 (10.7) | 0.67 |
SESa, n (%) | ||||||
High | 43 (36) | 36 (35) | 0.60 | 25 (41) | 44 (39) | 0.12 |
Intermediate | 49 (41) | 42 (41) | 15 (25) | 44 (39) | ||
Low | 21 (18) | 22 (22) | 12 (20) | 18 (16) | ||
Unknown | 6 (5) | 2 (2) | 9 (15) | 7 (6) | ||
Months since diagnosis, n (%) | ||||||
Median | 2.2 | 1.5 | < 0.01 | 3.0 | 2.4 | 0.31 |
< 1 | 12 (10) | 24 (24) | 8 (13) | 26 (23) | ||
1–2 | 40 (34) | 46 (45) | 18 (30) | 39 (34) | ||
2–3 | 33 (28) | 20 (20) | 8 (13) | 17 (15) | ||
> 3 | 34 (29) | 12 (12) | 27 (44) | 32 (28) | ||
Comorbidity, n (%) | ||||||
None | 19 (16) | 18 (18) | 0.53 | 21 (34) | 28 (25) | 0.18 |
1 | 32 (27) | 20 (20) | 12 (20) | 36 (32) | ||
2 or more | 64 (54) | 62 (61) | 26 (43) | 48 (36) | ||
Unknown | 4 (3) | 2 (2) | 2 (3) | 8 (7) | ||
Marital statusb, n (%) | ||||||
Partner | 85 (71) | 76 (75) | 0.74 | 48 (79) | 82 (73) | 0.39 |
No partner | 31 (26) | 25 (25) | 13 (21) | 31 (27) | ||
Unknown | 3 (3) | 1 (1) | 0 (0) | 0 (0) | ||
Employed, n (%) | ||||||
Yes | 22 (18) | 15 (15) | 0.40 | 20 (33) | 31 (27) | 0.44 |
No | 85 (71) | 79 (77) | 41 (67) | 83 (73) | ||
Unknown | 12 (10) | 8 (8) | 0 (0) | 0 (0) | ||
FIGO stage, n (%) | ||||||
I | 102 (85) | 89 (87) | 0.34 | 21 (34) | 31 (27) | 0.63 |
II | 6 (5) | 1 (1) | 7 (11) | 9 (8) | ||
II | 9 (8) | 9 (8) | 23 (38) | 50 (44) | ||
IV | 2 (2) | 3 (3) | 10 (16) | 20 (18) | ||
Unknown | 0 (0) | 0 (0) | 0 (0) | 3 (3) | ||
Treatment, n (%) | ||||||
Surgery | 117 (99) | 97 (98) | 0.46 | 54 (88) | 104 (93) | 0.33 |
Chemotherapy | 6 (5) | 12 (12) | 0.06 | 44 (72) | 92 (82) | 0.13 |
Radiotherapy | 44 (37) | 37 (37) | 0.99 |
Endometrial cancer | Ovarian cancer | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Illness perceptions after treatment | Symptoms experienced | Concerns | Emotional impact | Lower treatment trust | ||||||||
Months after treatment, outcome variables | 6 | 18 | 24 | 6 | 18 | 24 | 6 | 18 | 24 | 6 | 18 | 24 |
N
| 158 | 147 | 128 | 158 | 147 | 128 | 158 | 147 | 128 | 124 | 101 | 75 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Global quality of life | − 0.24 | − 0.25* | − 0.21 | − 0.25* | − 0.29* | − 0.34* | − 0.29* | − 0.29* | − 0.29* | − 0.42* | − 0.40* | − 0.36* |
Function scales | ||||||||||||
Physical functioning | − 0.22 | − 0.19 | − 0.24 | − 0.14 | − 0.21 | − 0.19 | − 0.18 | − 0.22 | − 0.18 | − 0.24 | − 0.16 | − 0.16 |
Role functioning | − 0.06 | − 0.20 | − 0.28* | − 0.09 | − 0.15 | − 0.36* | − 0.22 | − 0.13 | − 0.25 | − 0.27 | − 0.18 | − 0.25 |
Emotional functioning | − 0.34* | − 0.21 | − 0.32* | − 0.32* | − 0.24 | − 0.38* | − 0.38* | − 0.29* | − 0.41* | − 0.28* | − 0.15 | − 0.27 |
Cognitive functioning | − 0.17 | − 0.07 | − 0.25 | − 0.14 | − 0.17 | − 0.28* | − 0.17 | − 0.06 | − 0.22 | − 0.19 | − 0.29 | − 0.34 |
Social functioning | − 0.41* | − 0.28* | − 0.32* | − 0.23 | − 0.29* | − 0.38* | − 0.33* | − 0.27* | − 0.27* | − 0.16 | − 0.07 | − 0.26 |
Symptom scales | ||||||||||||
Fatigue | 0.36* | 0.28* | 0.34* | 0.26 | 0.26 | 0.37 | 0.35* | 0.31* | 0.32* | 0.26 | 0.14 | 0.29 |
Nausea and vomiting | 0.13 | 0.21 | 0.24 | 0.06 | 0.05 | 0.14 | 0.15 | 0.09 | 0.12 | 0.14 | 0.15 | 0.33 |
Pain | 0.23 | 0.17 | 0.26 | 0.20 | 0.23 | 0.39* | 0.22 | 0.20 | 0.26 | 0.28* | 0.19 | 0.33 |
Dyspnea | 0.18 | 0.19 | 0.11 | 0.07 | 0.14 | 0.14 | 0.15 | 0.15 | 0.20 | 0.20 | 0.02 | 0.23 |
Insomnia | 0.32* | 0.17 | 0.25 | 0.23 | 0.19* | 0.28* | 0.30* | 0.22 | 0.26 | 0.31* | 0.20 | 0.18 |
Appetite loss | 0.28* | 0.16 | 0.23 | 0.18 | 0.03 | 0.28* | 0.27* | 0.14 | 0.24 | 0.22 | 0.09 | 0.44* |
Constipation | 0.04 | 0.03 | 0.09 | 0.11 | 0.02 | 0.22 | 0.14 | 0.08 | 0.22 | 0.21 | 0.21 | 0.14 |
Diarrhea | 0.18 | 0.11 | 0.13 | 0.15 | 0.11 | 0.05 | 0.21 | 0.08 | 0.14 | 0.06 | < 0.01 | 0.13 |
Financial difficulties | 0.30* | 0.20* | 0.20 | 0.17 | 0.08 | 0.11 | 0.21 | 0.10 | 0.08 | 0.16 | 0.09 | − 0.08 |
Anxiety | 0.30* | 0.33* | 0.34* | 0.41* | 0.45* | 0.46* | 0.46* | 0.47* | 0.45* | 0.39* | 0.31 | 0.24 |
Depression | 0.39* | 0.28* | 0.23* | 0.35* | 0.35* | 0.36* | 0.39* | 0.33* | 0.34* | 0.40* | 0.25 | 0.38* |